Education
About Us
Working with TipRanks
Follow Us
MacroGenics (MGNX)
NASDAQ:MGNX
Total Valuation
MacroGenics has a market cap or net worth of $81.39M. The enterprise value is $39.31M.
Market Cap$81.39M
Enterprise Value$39.31M
Share Statistics
MacroGenics has 63.09M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63.09M
Owned by Insiders10.33%
Owned by Instutions0.05%
Financial Efficiency
MacroGenics’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -53.16%.
Return on Equity (ROE)-57.70%
Return on Assets (ROA)-25.59%
Return on Invested Capital (ROIC)-53.16%
Return on Capital Employed (ROCE)-53.65%
Revenue Per Employee$435,011.73
Profits Per Employee-$196,381.232
Employee Count341
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MacroGenics is -3.04. MacroGenics’s PEG ratio is >-0.01.
PE Ratio-3.04
PS Ratio1.36
PB Ratio1.75
Price to Fair Value1.75
Price to FCF-2.82
Price to Operating Cash Flow-2.98
PEG Ratio>-0.01
Income Statement
In the last 12 months, MacroGenics had revenue of $148.34M and earned -$66.97M in profits. Earnings per share was -$1.08.
Revenue$148.34M
Gross Profit$132.39M
Operating Income-$110.58M
Pretax Income-$66.02M
Net Income-$66.97M
EBITDA-57.37M
Earnings Per Share (EPS)-1.08
Cash Flow
In the last 12 months, operating cash flow was -$68.37M and capital expenditures -$3.71M, giving a free cash flow of -$72.08M billion.
Operating Cash Flow-$68.37M
Free Cash Flow-$72.08M
Free Cash Flow per Share-$1.14
Dividends & Yields
MacroGenics pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-35.42%
Earnings Yield-32.90%
Stock Price Statistics
Beta1.66
52-Week Price Change-92.50%
50-Day Moving Average2.10
200-Day Moving Average3.28
Relative Strength Index (RSI)32.03
Average Volume (3m)854.12K
Important Dates
MacroGenics upcoming earnings date is May 13, 2025, TBA.
Last Earnings DateMar 20, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
MacroGenics as a current ratio of 3.92, with Debt / Equity ratio of 0.32
Current Ratio3.92
Quick Ratio3.92
Debt to Market Cap0.18
Net Debt to EBITDA2.53
Interest Coverage Ratio-99.17
Taxes
In the past 12 months, MacroGenics has paid $2.74M in taxes.
Income Tax$2.74M
Effective Tax Rate-1.43%
Enterprise Valuation
MacroGenics EV to EBITDA ratio is -1.01, with an EV/FCF ratio of -0.81.
EV to Sales0.39
EV to EBITDA-1.01
EV to Free Cash Flow-0.81
EV to Operating Cash Flow-0.85
Balance Sheet
MacroGenics has $201.67M in cash and marketable securities with $37.46M in debt, giving a net cash position of -$164.21M billion.
Cash & Marketable Securities$201.67M
Total Debt$37.46M
Net Cash-$164.21M
Net Cash Per Share-$2.60
Tangible Book Value Per Share$1.85
Margins
Gross margin is 99.44%, with operating margin of -73.74%, and net profit margin of -44.66%.
Gross Margin99.44%
Operating Margin-73.74%
Pretax Margin-44.03%
Net Profit Margin-44.66%
EBITDA Margin-38.25%
EBIT Margin-43.28%
Analyst Forecast
The average price target for MacroGenics is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside372.44%
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast155.26%
EPS Growth Forecast-640.36%